Background: We investigated the differences between partial pressure of arterial carbon dioxide and end-tidal carbon dioxide (P(a-ET)CO2) with respect to the Broca-Katsura index (BKI), which is an obesity index, in ob...Background: We investigated the differences between partial pressure of arterial carbon dioxide and end-tidal carbon dioxide (P(a-ET)CO2) with respect to the Broca-Katsura index (BKI), which is an obesity index, in obese patients during general anesthesia. Materials and Methods: From January 2003 to December 2013, we studied 601 patients aged 16 years old or over undergoing general anesthesia. Patients had American Society of Anesthesiology physical status I and II and we reviewed their anesthetic charts. The P(a-ET)CO2 with respect to the BKI divided patients into two groups: 16 to 2 values between the two groups. Results: In patients aged 16 to 2 was 2.2 ± 3.1 mmHg at BKI 2 was 3.2 ± 4.1 mmHg at BKI 2 tends to increase in obese patients during general anesthesia with increasing BKI in patients aged 16 to < 65 years old.展开更多
目的探讨中心静脉-动脉血二氧化碳分压差[Pressure(central venous-arterial)carbon dioxide,P(cv-a)CO2]评价创伤性休克患者液体复苏效果的价值。方法选取我院创伤性休克液体复苏治疗患者119例,根据P(cv-a)CO2水平将患者分为观察组(<...目的探讨中心静脉-动脉血二氧化碳分压差[Pressure(central venous-arterial)carbon dioxide,P(cv-a)CO2]评价创伤性休克患者液体复苏效果的价值。方法选取我院创伤性休克液体复苏治疗患者119例,根据P(cv-a)CO2水平将患者分为观察组(<6 mm Hg,60例)和对照组(≥6 mm Hg,59例),比较两组患者液体复苏的效果。结果观察组中心静脉压、平均动脉压、中心静脉血氧饱和度和液体平衡量均明显高于对照组,去甲肾上腺素、多巴酚丁胺药物应用量明显低于对照组,两组比较差异均具有统计学意义(P<0.05),而观察组乳酸清除率、心脏指数明显高于对照组,血肌酐、APACHEⅡ评分和SOFA评分明显低于对照组,两组比较差异均具有统计学意义(P<0.05)。结论 P(cv-a)CO2对创伤性休克液体复苏效果具有重要的评价作用。展开更多
目的探讨中心静脉-动脉血二氧化碳分压差在反映感染性休克患者全身组织灌注的价值。方法对2011年3月至2013年5月在我院住院治疗的108例感染性休克患者进行回顾性研究,以P(cv-a)CO2值6 mm Hg为临界值,分成低P(cv-a)CO2组和高P(cv-a)CO2组...目的探讨中心静脉-动脉血二氧化碳分压差在反映感染性休克患者全身组织灌注的价值。方法对2011年3月至2013年5月在我院住院治疗的108例感染性休克患者进行回顾性研究,以P(cv-a)CO2值6 mm Hg为临界值,分成低P(cv-a)CO2组和高P(cv-a)CO2组,低P(cv-a)CO2组为58例,高P(cv-a)CO2组为50例,入选时定为0点,同时测定复苏6 h两组患者MAP、心率、APACHEⅡ评分、CVP、乳酸、ScvO2及CI。结果两组患者MAP、心率、APACHEⅡ评分、CVP、ScvO2、乳酸及CI治疗前后比较,差异有统计学意义(P<0.05);治疗后低P(cv-a)CO2组CVP、ScvO2及CI明显高于高P(cv-a)CO2组,两组相比差异有统计学意义(P<0.05)。结论 P(cv-a)CO2监测对于感染性休克患者全身组织灌注复苏有重要的意义,可以有效地判断患者组织灌注及疾病严重程度,值得临床推广应用。展开更多
文摘Background: We investigated the differences between partial pressure of arterial carbon dioxide and end-tidal carbon dioxide (P(a-ET)CO2) with respect to the Broca-Katsura index (BKI), which is an obesity index, in obese patients during general anesthesia. Materials and Methods: From January 2003 to December 2013, we studied 601 patients aged 16 years old or over undergoing general anesthesia. Patients had American Society of Anesthesiology physical status I and II and we reviewed their anesthetic charts. The P(a-ET)CO2 with respect to the BKI divided patients into two groups: 16 to 2 values between the two groups. Results: In patients aged 16 to 2 was 2.2 ± 3.1 mmHg at BKI 2 was 3.2 ± 4.1 mmHg at BKI 2 tends to increase in obese patients during general anesthesia with increasing BKI in patients aged 16 to < 65 years old.
文摘目的探讨中心静脉-动脉血二氧化碳分压差[Pressure(central venous-arterial)carbon dioxide,P(cv-a)CO2]评价创伤性休克患者液体复苏效果的价值。方法选取我院创伤性休克液体复苏治疗患者119例,根据P(cv-a)CO2水平将患者分为观察组(<6 mm Hg,60例)和对照组(≥6 mm Hg,59例),比较两组患者液体复苏的效果。结果观察组中心静脉压、平均动脉压、中心静脉血氧饱和度和液体平衡量均明显高于对照组,去甲肾上腺素、多巴酚丁胺药物应用量明显低于对照组,两组比较差异均具有统计学意义(P<0.05),而观察组乳酸清除率、心脏指数明显高于对照组,血肌酐、APACHEⅡ评分和SOFA评分明显低于对照组,两组比较差异均具有统计学意义(P<0.05)。结论 P(cv-a)CO2对创伤性休克液体复苏效果具有重要的评价作用。
文摘目的探讨中心静脉-动脉血二氧化碳分压差在反映感染性休克患者全身组织灌注的价值。方法对2011年3月至2013年5月在我院住院治疗的108例感染性休克患者进行回顾性研究,以P(cv-a)CO2值6 mm Hg为临界值,分成低P(cv-a)CO2组和高P(cv-a)CO2组,低P(cv-a)CO2组为58例,高P(cv-a)CO2组为50例,入选时定为0点,同时测定复苏6 h两组患者MAP、心率、APACHEⅡ评分、CVP、乳酸、ScvO2及CI。结果两组患者MAP、心率、APACHEⅡ评分、CVP、ScvO2、乳酸及CI治疗前后比较,差异有统计学意义(P<0.05);治疗后低P(cv-a)CO2组CVP、ScvO2及CI明显高于高P(cv-a)CO2组,两组相比差异有统计学意义(P<0.05)。结论 P(cv-a)CO2监测对于感染性休克患者全身组织灌注复苏有重要的意义,可以有效地判断患者组织灌注及疾病严重程度,值得临床推广应用。
